VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Fujikawa, Keiko ^a,c,d   Iwata, Takeshi ^b   Inoue, Kaoru ^c   Akahori, Masakazu ^b   Kadotani, Hanako ^a   Fukaya, Masahiro ^a   Watanabe, Masahiko ^a   Chang, Qing ^d   Barnett, Edward M ^d   Swat, Wojciech ^d  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LATANOPROST; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TIMOLOL MALEATE; UNCLASSIFIED DRUG; VAV 2 PROTEIN; VAV 3 PROTEIN; VAV PROTEIN; ANTIHYPERTENSIVE AGENT; PROSTAGLANDIN F; VAV2 PROTEIN, HUMAN; VAV2 PROTEIN, MOUSE; VAV3 PROTEIN, HUMAN; VAV3 PROTEIN, MOUSE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; CORNEA; DISEASE PREDISPOSITION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SCREENING; GLAUCOMA; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; IRIS; JAPANESE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OPTIC NERVE; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; RETINA; RETINA GANGLION CELL; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS GLAUCOMA; ANIMAL; ASIAN; BUPHTHALMOS; C57BL MOUSE; DRUG EFFECT; ETHNOLOGY; EYE; GENETIC PREDISPOSITION; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JAPAN; METABOLISM; MOUSE MUTANT; NERVE DEGENERATION; OPEN ANGLE GLAUCOMA; OPTIC DISK; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; MURINAE; MUS;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; EYE; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; HUMANS; HYDROPHTHALMOS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAOCULAR PRESSURE; JAPAN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE DEGENERATION; OPTIC DISK; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTAGLANDINS F, SYNTHETIC; PROTO-ONCOGENE PROTEINS C-VAV; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77949406694     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009050     Document Type: Article

References (49)

1. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, et al. (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120: 701-713.
2. AGIS investigators (2002) The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 429-440.
3. Gabelt BT, Kaufman PL (2005) Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 24: 612-637.
4. Tan JC, Peters DM, Kaufman PL (2006) Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol 17: 168-174.
5. Bustelo XR (2001) Vav protein, adaptors and cell signaling. Oncogene 20: 6372-6381.
6. Schmidt A, Hall A (2002) Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 16: 1587-1609.
7. Turner M, Billadeau DD (2002) VAV proteins as signal integrators for multisubunit immune-recognition receptors. Nat Rev Immunol 2: 476-486.
8. Swat W, Fujikawa K (2005) The Vav family: at the crossroads of signaling pathways. Immunol Res 32: 259-265.
9. Riteau B, Barber DF, Long EO (2003) Vav1 phosphorylation is induced byb2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med 198: 469-474.
10. Gakidis MAM, Cullere X, Olson T, Wilsbacher JL, Zhang B, et al. (2004) Vav GEFs are required for β2 integrin-dependent functions of neutrophils. J Cell Biol 166: 273-282.
11. Holsinger LJ, Graef IA, Swat W, Chi T, Bautista DM, et al. (1998) Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr Biol 8: 563-572.
12. Cella M, Fujikawa K, Tassi I, Kim S, Latinis K, et al. (2004) Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med 200: 817-823.
13. Doody GM, Bell SE, Vigorito E, Clayton E, McAdam S, et al. (2001) Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat Immunol 2: 542-547.
14. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, et al. (2005) Vav3 regulates osteoclast function and bone mass. Nat Med 11: 284-290.
15. Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, et al. (2003) Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med 198: 1595-1608.
16. Tybulewicz VLJ, Ardouin L, Prisco A, Reynolds LF (2003) Vav1: a key signal transducer downstream of the TCR. Immunol Rev 192: 42-52.
17. Karali A, Russell P, Stefani FH, Tamm ER (2000) Localization of myocilin/trabecular meshwork-inducible glucocorticoid response protein in the human eye. Invest Ophthalmol Vis Sci 41: 729-740.
18. Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL (2002) Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol 47 (suppl. 1): S53-S64.
19. Neufeld AH (1979) Experimental studies on the mechanism of action of timolol. Surv Ophthalmol 23: 363-370.
20. Pfeiffer N (1997) Dorzolamide: Development and clinical application of a topical carbonic anhydrase inhibitor. Surv Ophthalmol 42: 137-151.
21. Tanihara H, Inatani M, Honjo M, Tokushige H, Azuma J, et al. (2008) Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch Ophthalmol 126: 309-315.
22. Rao PV, Peterson YK, Inoue T, Casey PJ (2008) Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork. Invest Ophthalmol Vis Sci 49: 2464-2471.
23. Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, et al. (2001) Effects of Rho-associated protein kinase inhibitor, Y-27632, on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 42: 137-144.
24. Pang IH, Clark AF (2007) Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma 16: 483-505.
25. Aihara M, Lindsey JD, Weinreb RN (2003) Aqueous humor dynamics in mice. Invest Ophthalmol Vis Sci 44: 5168-5173.
26. Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, et al. (1999) Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 21: 405-409.
27. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, et al. (1998) Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 39: 951-962.
28. Goldblum D, Kipfer-Kauer A, Sarra GM, Wolf S, Frueh BE (2007) Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci 48: 5085-5090.
29. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW (2006) Progressive ganglion cells loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 7: 66.
30. Anderson MG, Smith RS, Hawes NL, Zabaleta A, Chang B, et al. (2002) Mutations in genes encoding melanosomal proteins cuase pigmentary glaucoma in DBA/2J mice. Nat Genet 1: 81-85.
31. Nakano M, Ikeda Y, Taniguchi T, Yagi T, Fuwa M, et al. (2009) Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population. Proc Natl Acad Sci U S A 106(31): 12838-12842.
32. Tanito M, Minami M, Akahori M, Kaidzu S, Takai Y, et al. (2008) LOXL1 variants in elderly Japanese patients with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract. Mol Vis 14: 1898-1905.
33. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, et al. (2008) Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci 49: 4453-4457.
34. Funayama T, Mashima Y, Ohtake Y, Ishikawa K, Fuse N, et al. (2006) SNPs and interaction analyses of noelin 2, myocilin, and optineurin genes in Japanese patients with open-angle glaucoma. Invest Ophthalmol Vis Sci 47: 5368-5375.
35. Inagaki Y, Mashima Y, Fuse N, Funayama T, Ohtake Y, et al. (2006) Polymorphism of b-adrenergic receptors and susceptibility to open-angle glaucoma. Mol Vis 12: 673-680.
36. Ishikawa K, Funayama T, Ohtake Y, Kimura I, Ideta H, et al. (2005) Association between glaucoma and gene polymorphism of endothelin type A receptor. Mol Vis 11: 431-437.
37. Jiao X, Yang Z, Yang X, Chen Y, Tong Z, et al. (2009) Common variants on chromosome 2 and risk of primary open-angle glaucoma in the Afro-Caribbean population of Barbados. Proc Natl Acad Sci U S A 106(40): 17105-17110.
38. Wolf C, Gramer E, Müller-Myhsok B, Pasutto F, Reinthal E, et al. (2009) Evaluation of nine candidate genes in patients with normal tension glaucoma: a case control study. BMC Med Genet 10: 91.
39. Narooie-Nejad M, Paylakhi SH, Shojaee S, Fazlali Z, Rezaei Kanavi M, et al. (2009) Loss of function mutations in the gene encoding latent transforming growth factor beta binding protein 2, LTBP2, cause primary congenital glaucoma. Hum Mol Genet 18(20): 3969-3977.
40. Sud A, Del Bono EA, Haines JL, Wiggs JL (2008) Fine mapping of the GLC1K juvenile primary open-angle glaucoma locus and exclusion of candidate genes. Mol Vis 4: 1319-1326.
41. Liu Y, Schmidt S, Qin X, Gibson J, Hutchins K, et al. (2008) Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations. Invest Ophthalmol Vis Sci 49(8): 3465-3468.
42. Thorleifsson G, Magnusson KP, Sulem P, Walters GB, Gudbjartsson DF, et al. (2007) Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 317(5843): 1397-1400.
43. Kumar A, Basavaraj MG, Gupta SK, Qamar I, Ali AM, et al. (2007) Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients. Mol Vis 13: 667-676.
44. Bill A, Svedberg B (1972) Scanning electron microscopic studies of the trabecular meshwork and the canal of Schlemm: an attempt to localize the main resistance to outflow of aqueous humor in man. Acta Ophthalmol 50: 295-320.
45. Wiedelholt M, Bielka S, Schweig F, Lütjen-Drecoll E, Lepple-Wienhues A (1995) Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp Eye Res 61: 223-234.
46. Filla MS, Woods A, Kaufman PL, Peters DM (2006) Beta1 and beta3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 47(5): 1956-1967.
47. Peterson JA, Sheibani N, David G, Garcia-Pardo A, Peters DM (2005) Heparin II domain of fibronectin uses alpha4beta1 integrin to control focal adhesion and stress fiber formation, independent of syndecan-4. J Biol Chem 25 280(8): 6915-6922.
48. Diskin S, Cao Z, Leffler H, Panjwani N (2009) The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading. Glycobiology 19(1): 29-37.
49. Fukaya M, Hayashi Y, Watanabe M (2005) NR2 to NR3B subnit switchover of NMDA receptors in early postnatal motoneurons. Eur J Neurosci 21: 1432-1436.